Kai Zhang
机构:Hebei Medical University, Academy of Medical Sciences, Zhejiang Sci-Tech University, Shandong University of Aeronautics, Huaibei Normal University, Bengbu Medical College, Longyan University, Shanghai Jiao Tong University, South China Normal University, Anhui Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing University of Information Science and Technology, Hainan University, Peking Union Medical College Hospital, China Academy of Engineering Physics, Zhengzhou University, Suihua University, Ministry of Education, Shanghai Stomatological Hospital, Shanghai Ninth People's Hospital, Shanghai Cancer Institute, Chaohu Hospital of Anhui Medical University, Ningxia Medical University, Henan Provincial People's Hospital, Zhengzhou Central Hospital, Henan Cancer Hospital, Zhengzhou People's Hospital, First Affiliated Hospital of Bengbu Medical College, Jiangsu Province Hospital, Anhui Mental Health Center, Shanghai Cell Therapy Research Institute, Third People's Hospital of Yunnan Province, Fourth Affiliated Hospital of Anhui Medical University, Pearl River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Nanjing Medical University, China Construction Bank
发表论文 338 篇 · 总被引 5973 次 · h-index 44
代表论文
- Development and Validation of a Cell-Free DNA Fragmentomics–Based Model for Early Detection of Pancreatic Cancer (2025 · Journal of Clinical Oncology · 被引 18)
- Autophagy‐Targeting Nanomedicine: Strike at the Heart of the Cancer via Precise Modulation of Autophagy (2025 · Exploration · 被引 9)
- Dimensionality control of chiral covalent organic frameworks for enhanced asymmetric catalysis (2025 · Chemical Engineering Journal · 被引 8)
- Chronic intermittent hypoxia increases Parkinson's disease susceptibility via PPARα-mediated lipid droplet-mitochondrial dysfunction (2025 · Theranostics · 被引 4)
- Mechanobiology of intervertebral disc degeneration: From pathological mechanisms to therapeutic approaches (2025 · Mechanobiology in Medicine · 被引 4)
- Metabolic dysfunction-associated steatotic liver disease increases the incidence of metachronous liver metastases from TNM stage 0–II colorectal cancer (2025 · Hepatology International · 被引 4)